tbuckley/cabot-search huggingface dataset:
Binding of Erythrocyte ICAM–4 to the Platelet Activated Integrin αIIbβ3 leads to a Direct Erythrocyte-Platelet Adhesion Under Venous Flow Shear Rate
Authors: Vivian Xiaoyan Du, Philip G de Groot, Richard van Wijk, Zaverio M. Ruggeri, Bas De Laat
Journal: Blood (2012)
Serum Cytochrome C as a Tumor Marker in Leukemia and Lymphoma.
Authors: Akemi Osaka, Takashi Sawada, Yasuaki Yamada, Muneo Aoyama, Hiroo Hasegawa, Daisuke Sasaki, Kazuto Tsuruda, Naoko Inokuchi, Shimeru Kamihira
Journal: Blood (2006)
PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project
Authors: Fred R. Hirsch, Abigail McElhinny, Dave Stanforth, James Ranger-Moore, Malinka Jansson, Karina Kulangara, William Richardson, Penny Towne, Debra Hanks, Bharathi Vennapusa, Amita Mistry, Rasika Kalamegham, Steve Averbuch, James Novotny, Eric Rubin, Kenneth Emancipator, Ian McCaffery, J. Andrew Williams, Jill Walker, John Longshore, Ming Sound Tsao, Keith M. Kerr
Journal: Journal of Thoracic Oncology (2016)
P0158 : Influence of sustained viral response in the regression of fibrosis and portal hypertension in cirrhotic HCV genotype 1 patients treated with triple therapy
Authors: A. Puente, J. Cabezas, M.T. Arias Loste, A. Estébanez, J.I. Fortea, A. Cuadrado, E. Fábrega, F. Casafont, J. Crespo
Journal: Journal of Hepatology (2015)
Progress with Scale-Up of HIV Viral Load Monitoring — Seven Sub-Saharan African Countries, January 2015–June 2016
Authors: Shirley Lecher, Jason Williams, Peter N. Fonjungo, Andrea A. Kim, Dennis Ellenberger, Guoqing Zhang, Christiane Adje Toure, Simon Agolory, Georgette Appiah-Pippim, Suzanne Beard, Marie Yolande Borget, Sergio Carmona, Geoffrey Chipungu, Karidia Diallo, Marie Downer, Dianna Edgil, Holly Haberman, Mackenzie Hurlston, Steven Jadzak, Charles Kiyaga, William MacLeod, Boniface Makumb, Hellen Muttai, Christina Mwangi, Jane W. Mwangi, Michael Mwasekaga, Mary Naluguza, Lucy W. Ng'Ang'A, Shon Nguyen, Souleymane Sawadogo, Katrina Sleeman, Wendy Stevens, Joel Kuritsky, Shannon Hader, John Nkengasong
Journal: MMWR Morbidity and Mortality Weekly Report (2016)

The World Health Organization (WHO) recommends viral load testing as the preferred method for monitoring the clinical response of patients with human immunodeficiency virus (HIV) infection to antiretroviral therapy (ART) (1). Viral load monitoring of patients on ART helps ensure early diagnosis and confirmation of ART failure and enables clinicians to take an appropriate course of action for patient management. When viral suppression is achieved and maintained, HIV transmission is substantially decreased, as is HIV-associated morbidity and mortality (2). CDC and other U.S. government agencies and international partners are supporting multiple countries in sub-Saharan Africa to provide viral load testing of persons with HIV who are on ART. This report examines current capacity for viral load testing based on equipment provided by manufacturers and progress with viral load monitoring of patients on ART in seven sub-Saharan countries (Côte d'Ivoire, Kenya, Malawi, Namibia, South Africa, Tanzania, and Uganda) during January 2015-June 2016. By June 2016, based on the target numbers for viral load testing set by each country, adequate equipment capacity existed in all but one country. During 2015, two countries tested >85% of patients on ART (Namibia [91%] and South Africa [87%]); four countries tested <25% of patients on ART. In 2015, viral suppression was >80% among those patients who received a viral load test in all countries except Côte d'Ivoire. Sustained country commitment and a coordinated global effort is needed to reach the goal for viral load monitoring of all persons with HIV on ART.
In Vivo Anti-Tumor Efficacy of Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®) in Multiple Myeloma
Authors: Eric Sanchez, Jeffrey A Steinberg, Mingjie Li, Haiming Chen, Benjamin Bonavida, Steven R. Deitcher, Anne E Hagey, James R. Berenson
Journal: Blood (2008)
Preparticipation physical examination: Is it time to stop doing the sports physical?
Authors: Michele LaBotz, David T Bernhardt
Journal: British Journal of Sports Medicine (2016)

For this issue of BJSM , we were charged with crafting a systematic review of how well the preparticipation physical evaluation (PPE) meets its objectives in paediatric athletes. According to the fourth edition PPE monograph, the primary objectives for the PPE are to screen for conditions that may be life-threatening, disabling or predispose to injury or illness.1 While substantial literature has emerged on cardiac and musculoskeletal screening in this group, there was insufficient information on the remainder of the evaluation, particularly in preadolescents, to produce a meaningful systematic review. This lack of evidence, and the evolution of the healthcare landscape, raises concern about resources currently used to conduct PPEs as a discrete clinical service, particularly when separated from broader preventive and screening services delivered by primary care providers (PCPs).

Current recommendations are for children and adolescents to accumulate 60 min of moderate to vigorous physical activity per day, with an emphasis on the need to include vigorous levels of exertion. Therefore, assessments to enhance safety during high-intensity physical activity and sport should …
Cutaneous T Cell Lymphoma: Responses in Phase 1 Trial of Combination Therapy with Liposomal Doxorubicin, Bortezomib, and Gemcitabine.
Authors: Navneet Dhillon, Srinivasa Bakkannagari, Chaan Ng, Joann Lim, Madeline Duvic, Razelle Kurzrock
Journal: Blood (2006)
Detrimental Role of Excess Adenosine-Mediated 2,3-Diphosphoglycerate Induction in Erythrocyte Sickling and Novel Mechanism-Based Therapies.
Authors: Yujin Zhang, Yingbo Dai, Jiaming Wen, Rodney E. Kellems, Michael R Blackburn, Harinder S. Juneja, Yang Xia
Journal: Blood (2009)
Effect of N-Acetyl-L-Cysteine on Cysteine Redox Status in Patients with Thrombotic Thrombocytopenic Purpura: Protein Disulfide Bound Cysteine As a Biomarker of Oxidative Stress
Authors: Xiaoyun Fu, Shelby A Cate, Junmei Chen, Tahsin Özpolat, Colette Norby, Barbara A Konkle, Jose A. Lopez
Journal: Blood (2015)
Chronic Graft vs. Host Disease (cGVHD) Hinders Long-Term Functional Recovery after Hematopoietic Cell Transplantation.
Authors: F. Lennie Wong, Liton Francisco, Stephen J. Forman, Mitzi Gonzales, Melanie Sabado, Cara Hanby, Marcia Grant, Smita Bhatia
Journal: Blood (2007)
Allogeneic Stem Cell Transplantation (SCT) Using Rabbit-ATG (Thymoglobulin®) and Low Dose Total Body Irradiation (TBI): Favorable Outcomes with Unrelated Donors (URD).
Authors: Amir A. Toor, Tulio Rodriguez, Najeeb Mohideen, Scott E. Smith, Mala Parthasarathy, John Norton, Jared Klein, Patrick J. Stiff
Journal: Blood (2005)
Avoidance of Post-Thaw Wash Prior to Transplantation of Plasma Depleted Cord Blood (PD CB) Is Associated with Improved Engraftment &amp; Decreased Severity of Chronic GvHD (cGvHD) without Increased Relapse.
Authors: Robert Chow, Brian Wang, Joseph Rosenthal, Auayporn Nademanee, Chatchada Karanes, Tang-Her Jaing, Michael Graham, Colleen Delaney, David Gjertson, Lawrence Petz, Stephen Forman, Joanne Kurtzberg
Journal: Blood (2007)
Immunomodulatory Effects of Histone Deacetylase 6 Inhibition in Suppressor Immune Cells in Multiple Myeloma
Authors: Gullu Gorgun, Teru Hideshima, Noopur S. Raje, Naoya Mimura, James E. Bradner, Diana Cirstea, Loredana Santo, Yu-Tzu Tai, Michael Sellitto, Yiguo Hu, Claire Fabre, Hiroto Ohguchi, Jiro Minami, Paul G. Richardson, Nikhil C. Munshi, Kenneth C. Anderson
Journal: Blood (2011)
Reaffirming and Clarifying the American Society of Clinical Oncology’s Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment
Authors: Jeffrey S. Weber, Laura A. Levit, Peter C. Adamson, Suanna S. Bruinooge, Howard A. Burris, Michael A. Carducci, Adam P. Dicker, Mithat Gönen, Stephen M. Keefe, Michael A. Postow, Michael A. Thompson, David M. Waterhouse, Susan L. Weiner, Lynn M. Schuchter
Journal: Journal of Clinical Oncology (2017)
A call for uniformity in implementing the IPAF (interstitial pneumonia with autoimmune features) criteria
Authors: Adelle S. Jee, Jane F. Bleasel, Stephen Adelstein, Gregory J. Keir, Tamera J. Corte
Journal: European Respiratory Journal (2016)

We commend Oldham et al . [1] for their recent article using the new European Respiratory Society/American Thoracic Society criteria for interstitial pneumonia with autoimmune features (IPAF) to re-characterise a cohort of interstitial lung disease (ILD) patients in their centre. IPAF defines individuals with interstitial pneumonia and features suggestive of a connective tissue disease (CTD), but not meeting established CTD classification criteria [2]. Of their 422 patients with previously diagnosed idiopathic interstitial pneumonia (IIP) or undifferentiated-CTD ILD (UCTD-ILD), approximately one-third met the IPAF criteria, including nearly 20% of those with idiopathic pulmonary fibrosis, 25% with unclassifiable IIP and almost all of those with UCTD-ILD [1]. Importantly, survival was markedly worse in the IPAF group compared with a CTD-ILD cohort [1]. Within the IPAF domains, the presence of at least one clinical criterion was predictive of a favourable outcome, while morphological, multi-compartment involvement carried a significantly increased risk of mortality [1]. There is an urgent need to standardise our approach to connective tissue disease classification in ILD and IPAF <http://ow.ly/IPm0304nLVV>
EB10, an Anti-FLT3 Monoclonal Antibody, Prolongs Survival and Reduces NOD/SCID Engraftment of AML Cell Lines and Primary Blasts.
Authors: Obdulio Piloto, Mark Levis, Li Li, Bao Nguyen, Kyu-Tae Kim, David Huso, Yiwen Li, Hongli Li, Mei-Nai Wang, Larry Witte, Daniel J. Hicklin, Donald Small
Journal: Blood (2004)
Reply to B. De Bari et al and J. Widder et al
Authors: Jianfei Shen, Chengyang Dai, Yaxing Shen, Rene Horsleben Petersen, Calvin S.H. Ng, Chia-Chuan Liu, Gaetano Rocco, Alessandro Brunelli, Chengchu Zhu, Chang Chen, Jianxing He
Journal: Journal of Clinical Oncology (2017)
Myelodysplastic Syndromes and Acute Myelogenous Leukemia Resulting from Therapy for Autoimmune Disease, a Case-Control Cohort Study
Authors: Natalie Ertz-Archambault, Heidi Kosiorek, Janna Castro, Gretchen Taylor, Robert Marino, Amylou Constance Dueck, Aref Al-Kali, Susanne Gauthier, Laura E. Finn, James M. Foran, Lisa Sproat, Raoul Tibes
Journal: Blood (2015)
Very Low to Low Doses of Continuous Azacitidine in Combination with Standard Doses of Lenalidomide and Low-Dose Dexamethasone (Rd) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Interim Results of a Phase I/II Study
Authors: Frederic J. Reu, Shahper N Khan, Reda Z Mahfouz, Robert M Dean, Beth Faiman, Janice Reed, Mary Ann Karam, Kimberly Hamilton, Sherry Fada, Matt Kalaycio, Erica L. Campagnaro, Tamila L. Kindwall-Keller, Jason Valent, Christy Samaras, Ronald Sobecks, Carolyn Jirousek, Hien K. Duong, Mohammed Orloff, Yogen Saunthararajah
Journal: Blood (2012)
Fludarabine, Mitoxantrone and Dexamethasone for the First Line Treatment of Patients with Indolent Non-Hodgkin Lymphoma (NHL): GATLA First Interim Report (Grupo Argentino de Tratamiento de la Leucemia Aguda).
Authors: Gustavo Milone, A. Rodriguez, Jorge Milone, R.F. Bezares, S. Rudoy, Luis Palmer, I. Cerruti, Francisco Lastiri
Journal: Blood (2006)
Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation (HSCT) with Mesenchymal Stem Cells (MSC) Infusion for Treatment of Metachromatic Leukodystrophy (MLD): A Case Report.
Authors: Nathalie Meuleman, C. Rocha, Jalil Bennani, Tatiana Tondreau, Alain Delforge, Philippe Lewalle, Philippe Martiat, Laurence Lagneaux, Dominique Bron
Journal: Blood (2006)
A Phase II Study of Vorinostat (MK-0683) in Patients with Polycythemia Vera and Essential Thrombocythemia
Authors: Christen Lykkegaard Andersen, Mary Frances McMullin, Elisabeth Ejerblad, Sonja Zweegman, Claire N Harrison, Savio Fernandes, David Bareford, Steven Knapper, Jan Samuelsson, Eva Löfvenberg, Olle Linder, Bjørn Andreasson, Erik Ahlstrand, Morten K. Jensen, Ole Weis Bjerrum, Hanne Vestergaard, Herdis Larsen, Tobias Wirenfeldt Klausen, Torben mourits-Andersen, Hans Hasselbalch
Journal: Blood (2012)
Only High Concentration of Immunoglobulin Inhibits Activation of Lymphocytes: Potential Use of Immunoglobulin for Preventing Gvhd
Authors: Hideaki Maeba, Rie Kuroda, Toshihiro Hujiki, Shintaro Mase, Raita Araki, Shoichi Koizumi, Akihiro Yachie, Ryosei Nishimura
Journal: Blood (2012)
FGF2-Containing Exosomes Secreted from Bone Marrow Stromal Cells Protect Leukemia Cells from Tyrosine Kinase Inhibitors
Authors: Jacqueline Martinez, Nathalie Javidi-Sharifi, Isabel English, Shelton A. Viola, Danielle Jorgens, Brian J. Druker, Elie Traer
Journal: Blood (2015)
Polyplexes assembled from self-peptides and regulatory nucleic acids blunt toll-like receptor signaling to combat autoimmunity
Authors: Krystina L. Hess, James I. Andorko, Lisa H. Tostanoski, Christopher M. Jewell
Journal: Biomaterials (2016)

Autoimmune diseases occur when the immune system incorrectly recognizes self-molecules as foreign; in the case of multiple sclerosis (MS), myelin is attacked. Intriguingly, new studies reveal toll-like receptors (TLRs), pathways usually involved in generating immune responses against pathogens, play a significant role in driving autoimmune disease in both humans and animal models. We reasoned polyplexes formed from myelin self-antigen and regulatory TLR antagonists might limit TLR signaling during differentiation of myelin-specific T cells, inducing tolerance by biasing T cells away from inflammatory phenotypes. Complexes were formed by modifying myelin peptide with cationic amino acids to create peptides able to condense the anionic nucleic-acid based TLR antagonist. These immunological polyplexes eliminate synthetic polymers commonly used to condense polyplexes and do not rely on gene expression; however, the complexes mimic key features of traditional polyplexes such as tunable loading and co-delivery. Using these materials and classic polyplex analysis techniques, we demonstrate condensation of both immune signals, protection from enzymatic degradation, and tunable physicochemical properties. We show polyplexes reduce TLR signaling, and in primary dendritic cell and T cell co-culture, reduce myelin-driven inflammation. During mouse models of MS, these tolerogenic polyplexes improve the progression, severity, and incidence of disease.
PR1 Vaccine Elicited Immunological Response after Hematopoietic Stem Cell Transplantation Is Associated with Better Clinical Response and Event-Free Survival.
Authors: Muzaffar H. Qazilbash, Eric D. Wieder, Peter F. Thall, Xuemei Wang, Rosa L. Rios, Sijie Lu, Shreya Kant, Sergio A. Giralt, Elihu H. Estey, Jorge Cortes, Krishna Komanduri, Richard E. Champlin, Jeffrey J. Molldrem
Journal: Blood (2007)
Imatinib-Resistant Activation of β-Catenin by BCR-ABL in a Murine Model of Chronic Myelogenous Leukemia Stem Cells.
Authors: Yosuke Minami, Scott Stuart, Tomokatsu Ikawa, Asoka Banno, Irina Hunton, Karl Willert, Cornelis Murre, Catriona Jamieson, Jean Y.J. Wang
Journal: Blood (2006)
New Perspectives in the Treatment of Colorectal Metastases
Authors: Dominique Elias, Luca Viganò, Franco Orsi, Marta Scorsetti, Tiziana Comito, Jan Lerut, Davide Cosola, Guido Torzilli
Journal: Liver Cancer (2016)

In recent years, the management of metastatic colorectal cancer has become more aggressive and more multidisciplinary. New treatment options have been proposed in addition to the standard approach of resection of liver metastases and chemotherapy.Selected patients with synchronous limited peritoneal and liver disease (peritoneal cancer index <12 and <3 liver metastases) can be scheduled for aggressive treatment, including cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, and liver resection. This approach has achieved survival benefits, even if the treatment is unlikely to be curative in most patients. Moreover, liver transplantation has been recently reconsidered for liver-only metastases, resulting in the de facto reinstatement of the chance of surgery for some unresectable patients. Even though indications for liver transplantation remain to be standardized, preliminary studies have reported extremely promising outcomes. Radio-embolization has proven to be an effective additional tool for the treatment of unresectable tumors, and its potential role in association with chemotherapy for resectable disease is currently being investigated. Stereotactic body radiation therapy is a safe, non-invasive, and effective therapeutic option for patients with inoperable oligometastatic disease. Thanks to recent technical progress, high radiation doses can now be delivered in fewer fractions with excellent local disease control and a low risk of radiation-induced liver injury. Finally, radiofrequency ablation (RFA) for colorectal metastases has become more effective, with results approaching those of surgical series. New interstitial treatments, such as microwave ablation and irreversible electroporation, could overcome some of the limitations of RFA, thereby further expanding indications and optimizing outcomes.Currently, a multidisciplinary approach to patients with colorectal liver metastases is mandatory. Aggressive surgical treatments should be integrated with all the available non-surgical options to maximize disease control and patient survival.
Multivirus-Specific T Cell Immunotherapy to Prevent or Treat Infections of Stem Cell Transplant Recipients.
Authors: Ulrike Gerdemann, Anne Christin, Carlos A. Ramos, Yuriko Fujita, Juan F. Vera, Dagmar Dilloo, Malcolm K. Brenner, Helen E. Heslop, Cliona M. Rooney, Ann M. Leen
Journal: Blood (2008)
Gene Expression Profiling Reveals Activation of Multiple Oncogenic Pathways and Over-Expression of Survivin in the Pathogenesis of Extranodal Nasal-Type NK/T Cell Lymphoma.
Authors: Wee-Joo Chng, Viknesvaran Selvarajan, Gaofeng Huang, Jianbiao Zhou, Mark Law, Andrew L Feldman, Salto-Tellez Manual, Siok-Bian Ng
Journal: Blood (2009)
Influence of Lower Dose Antithymocyteglobulin As Conditioning Regimen on Viral Infection after Haploidentical Allogeneic Stem Cell Transplantation
Authors: Ren Lin, Yu Wang, Fen Huang, Zhiping Fan, Shen Zhang, Ting Yang, Yajing Xu, Xinquan Liang, Yu Ji, Na Xu, Li Xuan, Jieyu Ye, Jing Sun, Xiaojun Huang, Qifa Liu
Journal: Blood (2016)
Intra-arterial Treatment for Basilar Artery Occlusion—Reply
Authors: Reinier C. van Houwelingen, Gert-Jan Luijckx, Maarten Uyttenboogaart
Journal: JAMA Neurology (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Neurology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Neurology journal
Should Internet Cognitive Behavioral Therapy for Insomnia Be the Primary Treatment Option for Insomnia?
Authors: Andrew D. Krystal, Aric A. Prather
Journal: JAMA Psychiatry (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Psychiatry HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Psychiatry journal
French Observatory of Adult' Chronic Immune Thrombocytopenia (ITP) Treated By Thrombopoietin Receptor Agonists (TPO-RAs)
Authors: Marc Michel, Daniel Adoue, Stéphane Cheze, Paul Coppo, Soraya Leclerc-Teffahi, Jerome Fernandes, Nathalie Texier
Journal: Blood (2015)
Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX): A Promising Regimen for Refractory/Relapsed B-Cell Lymphoma.
Authors: Taoufik El Gnaoui, Jehan Dupuis, Bertrand Joly, Karim Belhadj, Alain Rahmouni, Christiane Copie-Bergman, Antoine Allain, Isabelle Tabah-Fish, Felix Reyes, Corinne Haioun
Journal: Blood (2004)
Updated Results of High-Dose Yttrium 90 (90Y) Ibritumomab Tiuxetan with High-Dose Etoposide (VP-16) and Cyclophosphamide (CY) Followed by Autologous Hematopoietic Cell Transplant (AHSCT) for Poor-Risk or Refractory B-Cell Non-Hodgkin’s Lymphoma.
Authors: Auayporn Nademanee, Andrew Raubitschek, Arturo Molina, Joycelynne Palmer, Ni-Chun Tsai, Amrita Krishnan, Neil Kogut, Stephen Forman
Journal: Blood (2007)
Transformation of Chronic Lymphocytic Leukemia Into Diffuse Large B-Cell Lymphoma (Richter's Syndrome): Large Retrospective Analysis From a Single Institution.
Authors: Sameer A. Parikh, Kari G. Rabe, Neil E. Kay, Clive S. Zent, Timothy G. Call, Wei Ding, Curtis A. Hanson, William R Macon, Susan Schwager, Diane F. Jelinek, Susan L Slager, Tait D. Shanafelt
Journal: Blood (2012)
Tandem Transplantation in Multiple Myeloma Prolongs Survival, Predominantly in Patients Achieving Partial Remission after the First Cycle of High-Dose Therapy.
Authors: M.R. Nowrousian, M. Hoiczyk, S. Mueller, P. Schuett, T. Wrzeciono, M. Poser, D. Brandhorst, A. Welt, J. Hense, Michael Flasshove, K.A. Metz, S. Seeber, T. Moritz
Journal: Blood (2006)
The Role of Serum Immunoglobulin Free Light Chain In Response and Progression In Waldenstrom Macroglobulinemia
Authors: Xavier Leleu, Wanling Xie, Meghan Rourke, Ranjit Banwait, Renee Leduc, Nitin Roper, Edie Weller, Irene Ghobrial
Journal: Blood (2010)
Serum 2-Hydroxyglutarate Level Can Predict IDH2 Mutation in Myeloid Sarcoma
Authors: Christophe Willekens, Jean-Baptiste Micol, Vianney Poinsignon, Cyril Quivoron, Véronique Saada, Sophie Broutin, Marie Terroir-Cassou-Mounat, David Ghez, Jean-Henri Bourhis, Jacques Bosq, Vincent Ribrag, Angelo Paci, Virginie Lacronique-Penard, Stéphane De Botton
Journal: Blood (2015)
Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma
Authors: K T Siu, J Ramachandran, A J Yee, H Eda, L Santo, C Panaroni, J A Mertz, R J Sims III, M R Cooper, N Raje
Journal: Leukemia (2016)
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Patient-Derived Xenografts Are Faithful Genomic and Phenotypic Models of Primary Leukemia and Respond to the IL3 Receptor Targeting Agent SL-401 In Vivo
Authors: Amanda L Christie, Yvonne Li, Katsuhiro Togami, Mahmoud Ghandi, Alexandra N. Christodoulou, Kevin Buczkowski, Fanny Angelot-Delettre, Sabeha Biichle, Janice Chen, Christopher L. Brooks, David M. Weinstock, Francine Garnache-Ottou, Peter S Hammerman, Andrew A Lane
Journal: Blood (2015)